Oritavancin (LY 333328) 是一种具有口服活性的糖肽抗生素(antibiotic),对革兰氏阳性菌具有活性。Oritavancin 对多重耐药性S. pneumoniae表现出抗菌(antibacterial)作用。Oritavancin 抑制细胞壁合成,破坏膜电位。
| 生物活性 | Oritavancin (LY 333328) is an orally activeglycopeptideantibioticwith activity against gram-positive organisms. Oritavancin showsantibacterialeffect against multidrug-resistantS. pneumoniae. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential[1][2]. |
| IC50& Target | |
| Clinical Trial | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |